Biosimilar stewardship at the interface of disproportionality methods and AI integration: current evidence and potential strategies
Medium-term priorities include federated, KPI-linked analytics and better external validation and transportability; near-term 'assist' deployments - such as narrative NLP, normalization, de-duplication, and multi-feature ranking under human-in-the-loop governance - can quantifiably improve case completeness, traceability, and triage. To achieve reliable production use, persistent bottlenecks (class imbalance, vocabulary mapping) require clear monitoring and standard assessment procedures.
Authors
- Ahmad Z. Al Meslamani (ORCID: https://orcid.org/0000-0002-8370-9562)
- Abdullah Elrefae
- Eman Merghani Ali Mohammed
- Anan S. Jarab
Institutions
- Jordan University of Science and Technology (JO)
- Al Ain University (AE)
- Northwick Park Hospital (GB)
- Jazan University (SA)
Publication Details
- Journal
- Expert Opinion on Biological Therapy
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1080/14712598.2026.2631532
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00